Evaluation of Syndromic Surveillance in the Netherlands: Its Added Value and Recommendations for Implementation

Eurosurveillance

Volumn 16, Issue 9, 2011, Pages 1-8

  van den Wijngaard, C C ^a   van Pelt, W ^a   Nagelkerke, N J ^b   Kretzschmar, M ^a   Koopmans, M P ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ARTICLE; BACTERIAL VIRULENCE; CONSULTATION; DISEASE REGISTRY; DISEASE SURVEILLANCE; EPIDEMIC; FINANCIAL MANAGEMENT; FUNGAL VIRULENCE; GENERAL PRACTITIONER; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; LABORATORY TEST; MORTALITY; NETHERLANDS; PRESCRIPTION; RETROSPECTIVE STUDY; VIRUS VIRULENCE;

EID: 79952509218     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Cooper DL, Verlander NQ, Smith GE, Charlett A, Gerard E, Willocks L, et al. Can syndromic surveillance data detect local outbreaks of communicable disease? A model using a historical cryptosporidiosis outbreak. Epidemiol Infect. 2006;134(1):13-20.
2. Heffernan R, Mostashari F, Das D, Karpati A, Kuldorff M, Weiss D. Syndromic surveillance in public health practice, New York City. Emerg Infect Dis. 2004;10(5):858-864.
3. Bellika JG, Hasvold T, Hartvigsen G. Propagation of program control: a tool for distributed disease surveillance. Int J Med Inform. 2007;76(4):313-329.
4. Josseran L, Fouillet A, Caillère N, Brun-Ney D, Ilef D, Brucker G, et al. Assessment of a syndromic surveillance system based on morbidity data: results from the Oscour network during a heat wave. PLoS One. 2010;5(8):e11984.
5. Caudle JM, van Dijk A, Rolland E, Moore KM. Telehealth Ontario detection of gastrointestinal illness outbreaks. Can J Public Health. 2009;100(4):253-257.
6. van-Dijk A, Aramini J, Edge G, Moore KM. Real-time surveillance for respiratory disease outbreaks, Ontario, Canada. Emerg Infect Dis. 2009;15(5):799-801.
7. Hope K, Durrheim DN, d'Espaignet ET, Dalton C. Syndromic Surveillance: is it a useful tool for local outbreak detection? J Epidemiol Community Health. 2006;60(5):374-375.
8. Statistics Netherlands (CBS). Ziekteverzuim volgens de Nationale Verzuimstatistiek (tot 2006) [Absenteeism according to National Absenteeism Registry (until 2006)]. The Hague: CBS. [Accessed 1 Mar 2011]. Dutch. Available from: http://www.cbs.nl/nl-NL/menu/methoden/dataverzameling/ziekteverzuimvolgens-de-nationale-verzuimstatistiek.htm
9. The Netherlands Institute for Health Services Research (NIVEL). LINH: Landelijk informatienetwerk huisartsenzorg [LINH: the Netherlands Information Network of General Practice]. Utrecht: NIVEL. [Accessed 28 Feb 2011]. Dutch. Available from: http://www.nivel.nl/linh/
10. Stichting Farmaceutische Kengetallen (SFK). Foundation for pharmaceutical statistics. The Hague: SFK. [Accessed 28 Feb 2011]. Available from: http://www.sfk.nl/algemeen/english.html
11. Dutch Hospital Data (DHD). Landelijke Medische Registratie (LMR) [Dutch National Medical Register]. Utrecht: DHD. [Accessed 28 Feb 2011]. Available from: http://www.dutchhospitaldata.nl/Registraties/LMR.php?zoom_highlight=LMR
12. Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment, RIVM). Evaluatie van ISIS-MML [Evaluation of the Netherlands Infectious Diseases Surveillance Information System]. Bilthoven: RIVM. [Accessed 28 Feb 2011]. Dutch. Available from: http://www.rivm.nl/bibliotheek/rapporten/210211001.html
13. Statistics Netherlands (CBS). Doodsoorzakenstatistiek [Death cause statistics]. The Hague: CBS. [Accessed 1 Mar 2011]. Dutch. Available from: http://www.cbs.nl/nl-NL/menu/methoden/dataverzameling/doodsoorzakenstatistiek.htm
14. Statistics Netherlands (CBS). Bevolking per maand; leeftijd, geslacht, herkomst, generatie [Population by month; age, sex, origin of immigrants, generation]. The Hague: CBS. [Accessed 28 Feb 2011]. Dutch. Available from: http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=71090ned
15. The Netherlands Institute for Health Services Research (NIVEL). SuNN: Surveillance Netwerk Nederland [SuNN: Surveillance Network Netherlands]. Utrecht: NIVEL. [Accessed 28 Feb 2011]. Dutch. Available from: http://www.nivel.nl/sunn
16. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis. 2002;8(2):225-230.
17. Wagner MM, Dato V, Dowling JN, Allswede M. Representative threats for research in public health surveillance. J Biomed Inform. 2003;36(3):177-188.
18. Centers for Disease Control and Prevention (CDC). Syndrome definitions for diseases associated with critical bioterrorismassociated agents. Atlanta: CDC; 2003. Available from: http://www.bt.cdc.gov/surveillance/syndromedef/word/syndromedefinitions.doc
19. van den Wijngaard C, van Asten L, van Pelt W, Nagelkerke NJ, Verheij R, de Neeling AJ, et al. Validation of syndromic surveillance for respiratory pathogen activity. Emerg Infect Dis. 2008;14(6):917-925.
20. van Asten L, van den Wijngaard C, van Pelt W, van Vliet H, Koopmans M. Understanding the dynamics of gastro-intestinal syndrome: general practioner and hospital data vs laboratory surveillance. Advances in Disease Surveillance. 2007;2:215. Available from: http://www.isdsjournal.org/articles/949.pdf
21. van Asten L, van den Wijngaard C, Siebenga J, van Pelt W, van Vliet H, Koopmans M. Greater pathogenicity of norovirus strains in 2003? A syndromic approach. Advances in Disease Surveillance 2007;2:175. Available from: http://isdsjournal.org//articles/2825.pdf.
22. Rockx B, van Asten L, van den Wijngaard C, Godeke GJ, Goehring L, Vennema H, et al. Syndromic surveillance in the Netherlands for the early detection of West Nile virus epidemics. Vector Borne Zoonotic Dis. 2006;6(2):161-169.
23. Bourgeois FT, Olson KL, Brownstein JS, McAdam AJ, Mandl KD. Validation of syndromic surveillance for respiratory infections. Ann Emerg Med. 2006;47(3):265.e1.
24. Cooper DL, Smith GE, Edmunds WJ, Joseph C, Gerard E, George RC. The contribution of respiratory pathogens to the seasonality of NHS Direct calls. J Infect. 2007;55(3):240-248.
25. Terletskaia-Ladwig E, Enders G, Schalasta G, Enders M. Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study. BMC Infect Dis. 2005;5(1):20.
26. Simoes EA. Respiratory syncytial virus infection. Lancet. 1999;354(9181):847-852.
27. van den Wijngaard CC, van Asten L, Meijer A, van Pelt W, Nagelkerke NJ, Donker GA, et al. Detection of excess influenza severity: associating respiratory hospitalization and mortality data with reports of influenza-like illness by primary care physicians. Am J Public Health. 2010;100(11):2248-2254.
28. van 't Klooster TM, Wielders CC, Donker T, Isken L, Meijer A, van den Wijngaard CC, et al. Surveillance of hospitalizations for 2009 pandemic influenza A(H1N1) in the Netherlands, 5 June - 31 December 2009. Euro Surveill. 2010;15(2). pii: 19461. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19461
29. van den Wijngaard CC, van Asten L, van Pelt W, Doornbos G, Nagelkerke NJ, Donker GA, et al. Syndromic surveillance for local outbreaks of lower-respiratory infections: would it work? PLoS One. 2010;5(4):e10406.
30. van den Wijngaard CC, Dijkstra F, van Pelt W, van Asten L, Kretzschmar M, Schimmer B, et al. In search of hidden Q-fever outbreaks: linking syndromic hospital clusters to infected goat farms. Epidemiol Infect. 2011;139(1):19-26.
31. Blendon RJ, Benson JM, DesRoches CM, Raleigh E, Taylor- Clark K. The public's response to severe acute respiratory syndrome in Toronto and the United States. Clin Infect Dis. 2004;38(7):925-931.
32. Gesteland PH, Gardner RM, Tsui FC, Espino JU, Rolfs RT, James BC, et al. Automated syndromic surveillance for the 2002 Winter Olympics. J Am Med Inform Assoc. 2003;10(6):547-554.
33. Meyer N, McMenamin J, Robertson C, Donaghy M, Allardice G, Cooper D. A multi-data source surveillance system to detect a bioterrorism attack during the G8 Summit in Scotland. Epidemiol Infect. 2008;136(7):876-885.
34. van Asten L, van der Lubben M, van den Wijngaard C, van Pelt W, Verheij R, Jacobi A, et al. Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks. J Clin Virol. 2009;45(3):185-190.
35. van den Wijngaard CC, van Steenbergen JE, van der Sande MA, Koopmans MP. [New influenza A (H1N1): advised indication and prescription of antiviral drugs]. Ned Tijdschr Geneeskd. 2009;153:A1053.Dutch.
36. Travers D, Barnett C, Ising A, Waller A. Timeliness of emergency department diagnoses for syndromic surveillance. AMIA Annu Symp Proc 2006;769-773.
37. Nordin JD, Goodman MJ, Kulldorff M, Ritzwoller DP, Abrams AM, Kleinman K, et al. Simulated anthrax attacks and syndromic surveillance. Emerg Infect Dis. 2005;11(9):1394-1398.
38. Balter S, Weiss D, Hanson H, Reddy V, Das D, Heffernan R. Three years of emergency department gastrointestinal syndromic surveillance in New York City: what have we found? MMWR Morb Mortal Wkly Rep. 2005;54 Suppl:175-180.
39. Kirkwood A, Guenther E, Fleischauer AT, Gunn J, Hutwagner L, Barry MA. Direct cost associated with the development and implementation of a local syndromic surveillance system. J Public Health Manag Pract. 2007;13(2):194-199.
40. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis. 1997;3(2):83-94.
41. Dan YY, Tambyah PA, Sim J, Lim J, Hsu LY, Chow WL, et al. Costeffectiveness analysis of hospital infection control response to an epidemic respiratory virus threat. Emerg Infect Dis. 2009;15(12):1909-1916.
42. Brouwers L, Cakici B, Camitz M, Tegnell A, Boman M. Economic consequences to society of pandemic H1N1 influenza 2009 - preliminary results for Sweden. Euro Surveill. 2009;14(37). pii: 19333. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19333
43. World Health Organization (WHO). Pandemic influenza preparedness and response: a WHO guidance document. Geneva: WHO: 2009. Available from: http://www.who.int/csr/ disease/influenza/PIPGuidance09.pdf
44. National Government of the Netherlands. Elektronisch patiëntendossier. [Patient electronic medical record]. The Hague: National Government of The Netherlands [Accessed 28 Feb 2011]. Dutch. Available from: http://www.rijksoverheid.nl/onderwerpen/elektronisch-patientendossier#ref-minvws